Literature DB >> 20373415

A new paradigm for high-sensitivity 19F magnetic resonance imaging of perfluorooctylbromide.

Céline Giraudeau1, Julien Flament, Benjamin Marty, Fawzi Boumezbeur, Sébastien Mériaux, Caroline Robic, Marc Port, Nicolas Tsapis, Elias Fattal, Eric Giacomini, Franck Lethimonnier, Denis Le Bihan, Julien Valette.   

Abstract

In the present work, the NMR properties of perfluorooctylbromide are revisited to derive a high-sensitivity fluorine MRI strategy. It is shown that the harmful effects of J-coupling can be eliminated by carefully choosing the bandwidth of the 180 degrees pulses in a spin-echo sequence. The T(2) of the CF(3) resonance of the molecule is measured using a multispin-echo sequence and shown to dramatically depend on the interpulse delay. Following these observations, an optimized multispin-echo imaging sequence is derived and compared with short TE/pulse repetition time gradient echo and chemical shift imaging sequences. The unparalleled sensitivity yielded by the multispin-echo sequence is promising for future applications, in particular for targeted contrast agents such as perfluorooctylbromide nanoparticles.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20373415     DOI: 10.1002/mrm.22269

Source DB:  PubMed          Journal:  Magn Reson Med        ISSN: 0740-3194            Impact factor:   4.668


  17 in total

1.  Cell tracking using (19)F magnetic resonance imaging: technical aspects and challenges towards clinical applications.

Authors:  Houshang Amiri; Mangala Srinivas; Andor Veltien; Mark J van Uden; I Jolanda M de Vries; Arend Heerschap
Journal:  Eur Radiol       Date:  2014-11-06       Impact factor: 5.315

2.  Diffusional mechanisms augment the fluorine MR relaxation in paramagnetic perfluorocarbon nanoparticles that provides a "relaxation switch" for detecting cellular endosomal activation.

Authors:  Lingzhi Hu; Lei Zhang; Junjie Chen; Gregory M Lanza; Samuel A Wickline
Journal:  J Magn Reson Imaging       Date:  2011-07-14       Impact factor: 4.813

3.  Fluorous-Soluble Metal Chelate for Sensitive Fluorine-19 Magnetic Resonance Imaging Nanoemulsion Probes.

Authors:  Amin Haghighat Jahromi; Chao Wang; Stephen R Adams; Wenlian Zhu; Kazim Narsinh; Hongyan Xu; Danielle L Gray; Roger Y Tsien; Eric T Ahrens
Journal:  ACS Nano       Date:  2018-12-07       Impact factor: 15.881

4.  Chemical shift encoding (CSE) for sensitive fluorine-19 MRI of perfluorocarbons with complex spectra.

Authors:  Ruud B van Heeswijk; Roberto Colotti; Emeline Darçot; Jean Delacoste; Maxime Pellegrin; Davide Piccini; Diego Hernando
Journal:  Magn Reson Med       Date:  2017-09-01       Impact factor: 4.668

5.  A reference agent model for DCE MRI can be used to quantify the relative vascular permeability of two MRI contrast agents.

Authors:  Julio Cárdenas-Rodríguez; Christine M Howison; Terry O Matsunaga; Mark D Pagel
Journal:  Magn Reson Imaging       Date:  2013-04-11       Impact factor: 2.546

Review 6.  In vivo MRI cell tracking using perfluorocarbon probes and fluorine-19 detection.

Authors:  Eric T Ahrens; Jia Zhong
Journal:  NMR Biomed       Date:  2013-04-22       Impact factor: 4.044

7.  Balanced UTE-SSFP for 19F MR imaging of complex spectra.

Authors:  Matthew J Goette; Jochen Keupp; Jürgen Rahmer; Gregory M Lanza; Samuel A Wickline; Shelton D Caruthers
Journal:  Magn Reson Med       Date:  2014-08-27       Impact factor: 4.668

8.  Fluorine-19 magnetic resonance angiography of the mouse.

Authors:  Ruud B van Heeswijk; Yves Pilloud; Ulrich Flögel; Jürg Schwitter; Matthias Stuber
Journal:  PLoS One       Date:  2012-07-27       Impact factor: 3.240

Review 9.  Fluorine-19 MRI Contrast Agents for Cell Tracking and Lung Imaging.

Authors:  Matthew S Fox; Jeffrey M Gaudet; Paula J Foster
Journal:  Magn Reson Insights       Date:  2016-03-22

10.  Recent Advances in 19Fluorine Magnetic Resonance Imaging with Perfluorocarbon Emulsions.

Authors:  Anne H Schmieder; Shelton D Caruthers; Jochen Keupp; Samuel A Wickline; Gregory M Lanza
Journal:  Engineering (Beijing)       Date:  2016-03-16       Impact factor: 7.553

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.